Does androgen deprivation therapy protect against severe complications from COVID-19?

Patel, V G; Zhong, X; Liaw, B; Tremblay, D; Tsao, C-K; Galsky, M D; Oh, W K

Patel, V G; Zhong, X; Liaw, B; Tremblay, D; Tsao, C-K; Galsky, M D; Oh, W K.

Afiliação

Patel VG; Division of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA.
Zhong X; Department of Population Health and Policy, Icahn School of Medicine at Mount Sinai, New York, USA.
Liaw B; Division of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA.
Tremblay D; Division of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA.
Tsao CK; Division of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA.
Galsky MD; Division of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA.
Oh WK; Division of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA. Electronic address: william.oh@mssm.edu.

Ann Oncol ; 31(10): 1419-1420, 2020 10.

Article em En | MEDLINE | ID: mdl-32653425

Assuntos

Infecções por Coronavirus; Pandemias; Pneumonia Viral; Neoplasias da Próstata/epidemiologia; Síndrome Respiratória Aguda Grave; Antagonistas de Androgênios; Betacoronavirus; COVID-19; Humanos; Masculino; SARS-CoV-2

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pneumonia Viral / Neoplasias da Próstata / Infecções por Coronavirus / Síndrome Respiratória Aguda Grave / Pandemias Limite: Humans / Male Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google